Yekaterina Chudnovsky - 20 Jun 2025 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Director, 10%+ Owner
Signature
/s/ Yekaterina Chudnovsky
Issuer symbol
IMMX
Transactions as of
20 Jun 2025
Net transactions value
$0
Form type
4
Filing time
23 Jun 2025, 16:57:30 UTC
Previous filing
04 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chudnovsky Yekaterina Director, 10%+ Owner C/O IMMIX BIOPHARMA, INC., 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES /s/ Yekaterina Chudnovsky 23 Jun 2025 0001979324

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMMX Common Stock 3,241,076 20 Jun 2025 Held by GKCC, LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Option (Right to Buy) Award $0 +33,000 $0.000000 33,000 20 Jun 2025 Common Stock 33,000 $2.24 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC.
F2 The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.